University of Michigan
Short-term weight loss improved metabolic syndrome in overweight adults
Published in Cardiovascular Business Week, June 29th, 2004
"Impaired vascular endothelial function may be an important mechanism linking obesity to increased cardiovascular risk. We investigated whether short-term weight loss improves conduit artery endothelial dysfunction in overweight adults. Forty-three otherwise healthy overweight patients with a body mass index {{>=}}30 kg/m2 completed an open-label 3-month trial consisting of a calorie-restricted diet and 120 mg of orlistat taken three times daily with meals," investigators in the United States report.
"Endothelial function and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- ARYx Therapeutics Inc.
Pharmaceutical R&D company completes $55M Series D financing - Business and Finance
Psychiatric Solutions completes purchase of inpatient psychiatric facilities - Cardiac Science, Inc.
AED distribution pact signed for People's Republic of China - Edwards Lifesciences Corp.
John Cardis elected to board at cardiovascular disease company - Gamma Medica, Inc.
Cardiac gating subsystem available for X-SPECT preclinical imaging system - Medco Health Solutions, Inc.
Brand medications preferred over generics for serious conditions, survey shows - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
